Latest News "First Patient Treated in Trillium's Interstitial Cystitis/Bladder Pain Syndrome Clinical Trial" go »
For information on Trillium's interstitial cystitis/bladder pain syndrome
clinical study click here
Trillium Therapeutics Inc. (TTI) is a private research and development
biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation.
